BioKorea, inaugurated in 2006, has grown to be Asia’s premier event for the global biotech industry. At the 2018 event, 709 companies attended the conference, including 8 leading Australian biotech and medtech companies. The organiser of BioKorea, The Korea Health Industry Development Institute (KHIDI), has led large Korean delegations to AusBiotech over the past three years, demonstrating the strong interest Korean companies have in collaborating with Australia’s biotech industry.
At BioKorea 2019, AusBiotech and Austrade will co-organise the Australia National Pavilion and continue to capitalise on the strong foundations and interest to date between Australia and Korea.
To showcase Australian capabilities to the Korean industry this year’s event will feature seminars highlighting Australia’s capability in clinical trials and regenerative medicine as part of the official conference sessions.